NO883246L - Polyetylenglykolkarbaminat. - Google Patents

Polyetylenglykolkarbaminat.

Info

Publication number
NO883246L
NO883246L NO88883246A NO883246A NO883246L NO 883246 L NO883246 L NO 883246L NO 88883246 A NO88883246 A NO 88883246A NO 883246 A NO883246 A NO 883246A NO 883246 L NO883246 L NO 883246L
Authority
NO
Norway
Prior art keywords
formula
compounds
hydrogen
image
radical
Prior art date
Application number
NO88883246A
Other languages
English (en)
Other versions
NO171684C (no
NO883246D0 (no
NO171684B (no
Inventor
Heinrich Peter
Theophile Moerker
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO883246D0 publication Critical patent/NO883246D0/no
Publication of NO883246L publication Critical patent/NO883246L/no
Publication of NO171684B publication Critical patent/NO171684B/no
Publication of NO171684C publication Critical patent/NO171684C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/08Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/329Polymers modified by chemical after-treatment with organic compounds
    • C08G65/337Polymers modified by chemical after-treatment with organic compounds containing other elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/329Polymers modified by chemical after-treatment with organic compounds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/24Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Phenolic Resins Or Amino Resins (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
NO883246A 1987-07-23 1988-07-21 Analogifremgangsmaate til fremstilling av terapeutisk aktiv polyetylenglykolkarbaminater NO171684C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH279487 1987-07-23

Publications (4)

Publication Number Publication Date
NO883246D0 NO883246D0 (no) 1988-07-21
NO883246L true NO883246L (no) 1989-01-24
NO171684B NO171684B (no) 1993-01-11
NO171684C NO171684C (no) 1993-04-21

Family

ID=4241735

Family Applications (1)

Application Number Title Priority Date Filing Date
NO883246A NO171684C (no) 1987-07-23 1988-07-21 Analogifremgangsmaate til fremstilling av terapeutisk aktiv polyetylenglykolkarbaminater

Country Status (21)

Country Link
US (3) US5185368A (no)
EP (1) EP0300969B1 (no)
JP (1) JPH0813795B2 (no)
KR (1) KR890002250A (no)
AT (1) ATE117328T1 (no)
AU (1) AU617677B2 (no)
DD (1) DD281810A5 (no)
DE (1) DE3852793D1 (no)
DK (1) DK410988A (no)
ES (1) ES2066794T3 (no)
FI (1) FI93351C (no)
HU (1) HU201517B (no)
IE (1) IE65550B1 (no)
IL (1) IL87184A (no)
MX (1) MX12394A (no)
NO (1) NO171684C (no)
NZ (1) NZ225506A (no)
PH (1) PH26779A (no)
PT (1) PT88060B (no)
YU (1) YU142188A (no)
ZA (1) ZA885336B (no)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2052771T3 (es) * 1987-07-23 1994-07-16 Ciba Geigy Ag Procedimiento para la n-acilacion selectiva de derivados del acido amino-hidroxamico y los productos de partida empleados en el mismo.
MX12394A (es) * 1987-07-23 1993-12-01 Ciba Geigy Ag Procedimiento par la obtencion de carbamatos de polietilenglicol.
ATE77368T1 (de) * 1988-06-08 1992-07-15 Ciba Geigy Ag Carbamoylierte hydroxamsaeurederivate und verfahren zu ihrer herstellung.
US5122614A (en) * 1989-04-19 1992-06-16 Enzon, Inc. Active carbonates of polyalkylene oxides for modification of polypeptides
US5324844A (en) * 1989-04-19 1994-06-28 Enzon, Inc. Active carbonates of polyalkylene oxides for modification of polypeptides
US5693338A (en) 1994-09-29 1997-12-02 Emisphere Technologies, Inc. Diketopiperazine-based delivery systems
US6221367B1 (en) 1992-06-15 2001-04-24 Emisphere Technologies, Inc. Active agent transport systems
US6099856A (en) 1992-06-15 2000-08-08 Emisphere Technologies, Inc. Active agent transport systems
US5714167A (en) 1992-06-15 1998-02-03 Emisphere Technologies, Inc. Active agent transport systems
US5541155A (en) 1994-04-22 1996-07-30 Emisphere Technologies, Inc. Acids and acid salts and their use in delivery systems
US5629020A (en) 1994-04-22 1997-05-13 Emisphere Technologies, Inc. Modified amino acids for drug delivery
US5578323A (en) 1992-06-15 1996-11-26 Emisphere Technologies, Inc. Proteinoid carriers and methods for preparation and use thereof
US6331318B1 (en) 1994-09-30 2001-12-18 Emisphere Technologies Inc. Carbon-substituted diketopiperazine delivery systems
US5447728A (en) * 1992-06-15 1995-09-05 Emisphere Technologies, Inc. Desferrioxamine oral delivery system
US5443841A (en) 1992-06-15 1995-08-22 Emisphere Technologies, Inc. Proteinoid microspheres and methods for preparation and use thereof
US5310539A (en) * 1991-04-15 1994-05-10 Board Of Regents, The University Of Texas System Melanin-based agents for image enhancement
US5254724A (en) * 1991-10-30 1993-10-19 University Of Florida Research Foundation, Inc. Method for synthesis of desferrioxamine B, analogs and homologs thereof
GB9211779D0 (en) * 1992-06-03 1992-07-15 Ciba Geigy Ag Amine salts
US5811127A (en) 1992-06-15 1998-09-22 Emisphere Technologies, Inc. Desferrioxamine oral delivery system
US5792451A (en) 1994-03-02 1998-08-11 Emisphere Technologies, Inc. Oral drug delivery compositions and methods
US5489491A (en) * 1992-07-22 1996-02-06 Golovin; Milton N. Curable polymer precursors for solid electrolytes
US5401516A (en) * 1992-12-21 1995-03-28 Emisphere Technologies, Inc. Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
US6461643B2 (en) * 1993-04-22 2002-10-08 Emisphere Technologies, Inc. Oral drug delivery compositions and methods
US5643957A (en) 1993-04-22 1997-07-01 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5958457A (en) 1993-04-22 1999-09-28 Emisphere Technologies, Inc. Compositions for the delivery of antigens
US5709861A (en) 1993-04-22 1998-01-20 Emisphere Technologies, Inc. Compositions for the delivery of antigens
ATE298561T1 (de) 1993-04-22 2005-07-15 Emisphere Tech Inc Orale dareichungsform
US5605672A (en) * 1993-06-09 1997-02-25 The General Hospital Corporation Blood pool imaging composition and method of its use
IL106064A (en) * 1993-06-18 1997-11-20 Yissum Res Dev Co Gallium complexes for the treatment of free radical-induced diseases
US5618838A (en) * 1993-06-18 1997-04-08 Yissum Research Development Company Of The Hebrew University Of Jerusalem Gallium complexes for the treatment of free radical-induced diseases
US6090958A (en) 1995-03-31 2000-07-18 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
BR9604880A (pt) 1995-03-31 1998-05-19 Emisphere Tech Inc Composto composição forma de unidade de dosagem métodos para administração de um agente biologicamente ativo para preparar uma composição para administração de um agente ativo e para preparar um composto e composição farmacológica
US6001347A (en) 1995-03-31 1999-12-14 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5650386A (en) 1995-03-31 1997-07-22 Emisphere Technologies, Inc. Compositions for oral delivery of active agents
US5866536A (en) 1995-03-31 1999-02-02 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5965121A (en) 1995-03-31 1999-10-12 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5989539A (en) 1995-03-31 1999-11-23 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5820881A (en) 1995-04-28 1998-10-13 Emisphere Technologies, Inc. Microspheres of diamide-dicarboxylic acids
US5750147A (en) 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
US6051258A (en) 1995-06-07 2000-04-18 Emisphere Technologies, Inc. Proteinoid emulsions and methods for preparation and use thereof
US5667806A (en) 1995-06-07 1997-09-16 Emisphere Technologies, Inc. Spray drying method and apparatus
US5824345A (en) 1995-06-07 1998-10-20 Emisphere Technologies, Inc. Fragrances and flavorants
DE19681560T1 (de) 1995-09-11 1998-08-20 Emisphere Tech Inc Verfahren zur Herstellung von omega-Aminoalkansäure-Derivaten aus Cycloalkanonen
US7026116B1 (en) * 1996-04-04 2006-04-11 Bio-Rad Laboratories, Inc. Polymorphisms in the region of the human hemochromatosis gene
US6140305A (en) * 1996-04-04 2000-10-31 Bio-Rad Laboratories, Inc. Hereditary hemochromatosis gene products
US6849399B1 (en) 1996-05-23 2005-02-01 Bio-Rad Laboratories, Inc. Methods and compositions for diagnosis and treatment of iron misregulation diseases
CA2258264A1 (en) 1996-06-14 1997-12-18 Emisphere Technologies, Inc. Microencapsulated fragrances and method for preparation
US5879681A (en) 1997-02-07 1999-03-09 Emisphere Technolgies Inc. Compounds and compositions for delivering active agents
US5990166A (en) 1997-02-07 1999-11-23 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5804688A (en) 1997-02-07 1998-09-08 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6358504B1 (en) 1997-02-07 2002-03-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5939381A (en) 1997-02-07 1999-08-17 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6060513A (en) 1997-02-07 2000-05-09 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5876710A (en) 1997-02-07 1999-03-02 Emisphere Technologies Inc. Compounds and compositions for delivering active agents
US6313088B1 (en) 1997-02-07 2001-11-06 Emisphere Technologies, Inc. 8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents
US5863944A (en) 1997-04-30 1999-01-26 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5962710A (en) 1997-05-09 1999-10-05 Emisphere Technologies, Inc. Method of preparing salicyloylamino acids
ATE462717T1 (de) 1997-06-13 2010-04-15 Bio Rad Laboratories Verfahren und zusammensetzungen für die diagnose und die behandlung von krankheiten, die mit eisenüberschuss oder eisenmangel assoziiert sind
EP1146860A4 (en) * 1999-01-08 2002-07-03 Emisphere Tech Inc POLYMER DRUG DELIVERY SYSTEMS AND COMPOUNDS
US6767741B1 (en) 1999-08-27 2004-07-27 Invitrogen Corporation Metal binding compounds and their use in cell culture medium compositions
US6648864B2 (en) * 2000-12-12 2003-11-18 The Procter & Gamble Company Array of disposable absorbent article configurations and merchandise display system for identifying disposable absorbent article configurations for wearers
CA2457876C (en) 2001-08-22 2011-10-11 Bioartificial Gel Technologies Inc. Process for the preparation of activated polyethylene glycols
US7351787B2 (en) * 2004-03-05 2008-04-01 Bioartificial Gel Technologies, Inc. Process for the preparation of activated polyethylene glycols
US8454934B2 (en) 2006-05-25 2013-06-04 Canadian Blood Services High molecular weight chelation structure
DE102007008655A1 (de) * 2007-02-20 2008-08-21 Henkel Ag & Co. Kgaa Siderophor-Metall-Komplexe als Bleichkatalysatoren
AU2010228926B2 (en) * 2009-03-26 2015-12-10 Warsaw Orthopedic, Inc. Methods of identifying potential components for targeted drug delivery compositions
MX2018009662A (es) * 2016-02-11 2018-09-11 Chevion Mordechai Metodo y composicion farmaceutica para tratamiento de neurodegeneracion.
CN115109045A (zh) * 2022-07-14 2022-09-27 大连大学 一种生物基杂环单体及其均聚酯的制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1163337B (de) * 1960-10-11 1964-02-20 Ciba Geigy Verfahren zur Herstellung von Trihydroxamsaeuren
US3471476A (en) * 1964-05-18 1969-10-07 Tino Gaeumann Trihydroxamic acids
US3634407A (en) * 1969-06-19 1972-01-11 Ciba Geigy Corp Heavy metal complexes of trihydroxamic acids
US4612122A (en) * 1981-06-29 1986-09-16 Clara Ambrus Removing heavy metal ions from blood
US4419365A (en) * 1981-12-21 1983-12-06 Ciba-Geigy Corporation Method of treating Alzheimer's disease
US4671901A (en) * 1984-01-26 1987-06-09 Oral-D Orally effective ion chelators
US4684482A (en) * 1984-01-26 1987-08-04 Oral-D (L.P.) Orally effective ion chelators
US4613616A (en) * 1984-07-20 1986-09-23 Research Corporation Polymeric iron chelators
AU596791B2 (en) * 1984-12-19 1990-05-17 Ciba-Geigy Ag New carbonic acid esters
US5089644A (en) * 1985-01-04 1992-02-18 Salutar Inc. Preparation of oxamine complexes
US4758422A (en) * 1985-01-04 1988-07-19 Salutar Inc. Ferrioxamine paramagnetic contrast agents for MR imaging
US4637929A (en) * 1985-01-04 1987-01-20 Salutar, Inc. Ferrioxamine-paramagnetic contrast agents for MR imaging, composition, apparatus and use
US4835269A (en) * 1985-11-11 1989-05-30 Ceskoslovenska Akademie Ved Silane reagents containing a complexon group
JPH07110815B2 (ja) * 1985-11-18 1995-11-29 ボ−ド・オブ・リ−ジェンツ、ザ・ユニバ−シティ−・オブ・テキサス・システム 画像及びスペクトル向上(およびスペクトルシフト)のためのポリキレ−ト剤
US4940811A (en) * 1986-12-09 1990-07-10 Ciba-Geigy Corporation N,N-disubstituted ureas and processes for their manufacture
ES2052771T3 (es) * 1987-07-23 1994-07-16 Ciba Geigy Ag Procedimiento para la n-acilacion selectiva de derivados del acido amino-hidroxamico y los productos de partida empleados en el mismo.
MX12394A (es) * 1987-07-23 1993-12-01 Ciba Geigy Ag Procedimiento par la obtencion de carbamatos de polietilenglicol.
DE58906384D1 (de) * 1988-01-20 1994-01-27 Ciba Geigy Verfahren zur Herstellung von Komplexverbindungen.
GB8808305D0 (en) * 1988-04-08 1988-05-11 Nycomed As Compositions
US4999445A (en) * 1988-06-10 1991-03-12 The Regents Of The University Of California Contrast agents for magnetic resonance imaging of the small intestine and hepatobiliary system
IL91047A (en) * 1989-07-19 1993-06-10 Yissum Res Dev Co Zinc complexes for the treatment of free radical- induced diseases

Also Published As

Publication number Publication date
JPS6447749A (en) 1989-02-22
IE65550B1 (en) 1995-11-01
IL87184A0 (en) 1988-12-30
IL87184A (en) 1993-04-04
EP0300969A2 (de) 1989-01-25
NO171684C (no) 1993-04-21
US5185368A (en) 1993-02-09
ATE117328T1 (de) 1995-02-15
PH26779A (en) 1992-10-13
US5328992A (en) 1994-07-12
HUT47529A (en) 1989-03-28
DK410988D0 (da) 1988-07-22
FI93351C (fi) 1995-03-27
JPH0813795B2 (ja) 1996-02-14
US5424057A (en) 1995-06-13
YU142188A (en) 1990-04-30
EP0300969A3 (en) 1990-12-19
PT88060A (pt) 1989-06-30
PT88060B (pt) 1995-03-01
EP0300969B1 (de) 1995-01-18
DK410988A (da) 1989-01-24
KR890002250A (ko) 1989-04-10
FI883470A0 (fi) 1988-07-22
MX12394A (es) 1993-12-01
HU201517B (en) 1990-11-28
AU1929088A (en) 1989-01-27
ZA885336B (en) 1989-03-29
NO883246D0 (no) 1988-07-21
NZ225506A (en) 1990-12-21
FI883470A (fi) 1989-01-24
IE882249L (en) 1989-01-23
NO171684B (no) 1993-01-11
FI93351B (fi) 1994-12-15
DE3852793D1 (de) 1995-03-02
DD281810A5 (de) 1990-08-22
AU617677B2 (en) 1991-12-05
ES2066794T3 (es) 1995-03-16

Similar Documents

Publication Publication Date Title
NO883246L (no) Polyetylenglykolkarbaminat.
SE7908727L (sv) Fosfinylalkanoylproliner
NO931793L (no) Polyazamakrocykliske forbindelser for metallionkompleksdannelse
ES2086094T3 (es) Nuevas alquilamino-mercaptoalquilamidas o una de sus sales cosmeticamente aceptables, y su utilizacion como agentes reductores, en un procedimiento de deformacion permanente de los cabellos.
ATE61374T1 (de) Diaminoandrostanderivate.
FI823282A0 (fi) Octahydronaftalenderivater och deras framstaellning
DK0460488T3 (da) Svovlholdige heterocykliske forbindelser
DK288686A (da) Farmaceutiske praeparater
ES2046229T3 (es) Composicion antiulcerosa.
DE3372364D1 (en) 1-carboxyalkanoylperhydroindole-2-carboxylic acids and derivatives
FI830397A0 (fi) Foerfarande foer framstaellning av imidazolidinderivat
ATE9347T1 (de) Salze von endo-8-methyl-8-syn-alkyl-8-
IL90559A0 (en) Analgetic derivatives of phenothiazine
FI823458A0 (fi) Substituerade tiazolidinylestrar av mineralsyror
ES445944A1 (es) Procedimiento de preparacion de derivados de 8-amino-teofi- lina.
ATE40677T1 (de) Diaminderivate.
GR3005867T3 (no)
NO932251L (no) Chelaterende forbindelser
IT1141104B (it) Acaricidi attivi contro le uova ibernanti
TH13243EX (th) อนุพันธ์ไธอะโซลิดิโนนและออกซาโซลิดิโนนและการเตรียมสารนั้นและการใช้เป็นยาทำให้หลอดเลือดขยายตัว
TH3875A (th) สารฆ่าวัชพืช n-(ฟอสฟอโนเมธิลไกลซิล) ซัลฟอนิแลมีน